Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05764083 · ClinicalTrials.gov registry record

Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3)

A clinical trial of COVID-19 and SARS-CoV-2, sponsored by VA Office of Research and Development.

Completed
Registry status
2,824
Enrollment target
1
Study location

NCT05764083 is a study of COVID-19 and SARS-CoV-2 that has completed, run by VA Office of Research and Development. The registered enrollment target is 2,824 participants, below the 55,201-participant average among 203 other COVID-19 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05764083, a study of COVID-19 and SARS-CoV-2, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
2,824 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to gather information to answer questions about the Coronavirus Disease 2019 (COVID-19) which is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. This study will collect information and biological specimens from participants who have been tested for the SARS-CoV-2 infection. By doing this study, the investigators hope to learn important new information about SARS-CoV-2 infections and the potentially severe outcomes of COVID-19 to find better ways to manage and treat it in the future. The investigators also hope to learn what makes some people more susceptible to infection to help better inform Veterans on how to reduce their risk of infection. This study also involves the development and maintenance of a participant registry, a data repository, and a biorepository for future research.

Conditions Studied

COVID-19 SARS-CoV-2

Study Locations (1)

California

  • VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto

Trial Details

FieldValue
Enrollment Target 2,824 participants
Start Date 2020-07-22
Est. Completion 2024-09-30

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05764083

The ClinicalTrials.gov registry entry for NCT05764083 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,824 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,201-participant average among 203 other COVID-19 trials with a reported enrollment target (95% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 0 interventions.

NCT05764083 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05764083 about?

NCT05764083 is a clinical study titled "Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3)". The purpose of this research is to gather information to answer questions about the Coronavirus Disease 2019 (COVID-19) which is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. This study will collect information and biological specimens from participants who ha...

What is the current status of trial NCT05764083?

This trial is currently completed. The enrollment target is 2,824 participants. The study started on 2020-07-22. Estimated completion is 2024-09-30.

What conditions does trial NCT05764083 study?

This clinical trial studies the following conditions: COVID-19, SARS-CoV-2.

Who is sponsoring clinical trial NCT05764083?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05764083 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

SARS-CoV-2

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.